Table I.
Immunoglobulin brand characteristics∗
| Brand | Number of lots tested | Site of administration | Route of administration | Date of expiration |
|---|---|---|---|---|
| Cuvitru | 5 | Home infusion | SC | 2023–2024 |
| Gammagard | 31 | Home infusion and infusion center | IV | 2020–2024 |
| Gammagard SD | 8 | Home infusion and infusion center | IV | 2020–2023 |
| Gammaplex | 4 | Home infusion | IV | 2023–2024 |
| Gamunex-C | 35 | Home infusion and infusion center | IV (mostly) and SC | 2020–2024 |
| Hizentra | 21 | Home infusion | SC | 2021–2023 |
| Hyqvia | 6 | Home infusion | SC | 2022–2023 |
| Octagam | 6 | Infusion center | IV | 2020–2023 |
| Panzyga | 4 | Home infusion | IV | 2023–2024 |
| Privigen | 2 | Home infusion | SC | 2022 |
| Xembify | 3 | Home infusion | IV | 2023–2024 |
∗
Prepandemic samples correspond to an expiration year of 2020.